Raymond James Financial’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Sell
603,153
-426,655
-41% -$91.5M 0.03% 466
2026
Q1
$228M Sell
1,029,808
-38,726
-4% -$9.47M 0.07% 248
2025
Q4
$271M Sell
1,068,534
-26,424
-2% -$6.64M 0.08% 208
2025
Q3
$271M Sell
1,094,958
-240
-0% -$57.4K 0.09% 211
2025
Q2
$263M Sell
1,095,198
-5,873
-0.5% -$1.37M 0.09% 204
2025
Q1
$250M Buy
1,101,071
+11,428
+1% +$2.51M 0.09% 204
2024
Q4
$224M Buy
+1,089,643
New +$239M 0.08% 216

Other funds holding STE

Raymond James Financial's STE Position: Q2 2026 in Review

Raymond James Financial reduced its Steris (STE) stake by 41% in Q2 2026, selling an estimated $91.5M and leaving 603,153 shares worth $127M. The position accounts for 0.03% of the portfolio, ranked #466.

Raymond James Financial first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $271M in Q3 2025. 833 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Raymond James Financial held 603,153 shares of Steris worth $127M as of Q2 2026.
  • Raymond James Financial sold 426,655 Steris shares in Q2 2026, an estimated $91.5M.
  • Steris made up 0.03% of Raymond James Financial's portfolio in Q2 2026, its #466 holding.
  • Raymond James Financial first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Steris position peaked at $271M in Q3 2025.
  • 833 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.